Jan Biotech Inc (AKA: JBI) Profile last edited on: 12/4/2017
CAGE: 71ZJ8
UEI: DKDUTDKCJQE6
Business Identifier: Diagnosis and evaluation of HIV based on cell-based mRNA production of HIV cells. 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 23
County: Tompkins
Congr. District: 23
County: Tompkins
Public Profile
Jan Biotech is focused on developing nanotechnologies for molecular diagnostic assays of infectious diseases, particularly HIV. The company was founded based on a diagnostic platform that provides real-time quantitation of cell-based mRNA produced by latent HIV-infected cells. The platform can differentiate between cellular proviral and viral RNA in latent resevoirs of HIV-infected cells in HAART patients. The aim is to evaluate the development of the disease and monitor the success of antiviral treatments. The firm's intellectual properties include novel molecular in vitro assays for clinical diagnosis and quantification of latent infections such as HIV-1, as well as detection of aggressive cancer (ex., prostate) and cancer treatment monitoring
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
1-4Awards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2023 | 1 | NIH | $300,000 | |
| Project Title: Pediatric Latent HIV Reservoir Characterization and Quantification Assay | ||||
| 2023 | 2 | NIH | $2,291,256 | |
| Project Title: Sequence-based RNA Fluorescence Assay to Measure Latent HIV Reservoirs | ||||
| 2022 | 1 | NIH | $275,766 | |
| Project Title: Rapid COVID-19 Mutation Discrimination Test for Global SARS-CoV-2 Variant Surveillance | ||||
| 2019 | 1 | Army | $150,000 | |
| Project Title: Hybrid Nano-Bio-Electronic Odor Detector | ||||
| 2019 | 2 | NIH | $3,354,380 | |
| Project Title: Real-Time Spliced-Rna Detection to Quantify Latent Hiv-Infected Cells in Haart Patients | ||||
Key People / Management
Jennifer A Nichols -- President
Janet L Huie -- Co-Founder and CSO
Deborah Kuzmanovic -- Director of R&D
David A Putnam -- STTR Contract Partner
Janet L Huie -- Co-Founder and CSO
Deborah Kuzmanovic -- Director of R&D
David A Putnam -- STTR Contract Partner
Company News
There are no news available.
